Expedition Therapeutics

Expedition Therapeutics, Inc. was founded in March 2024, with its registration location in Delaware, USA, and Yi Larson serving as the Chairman and CEO. Expedition Therapeutics is a biotechnology company focused on the research and development of innovative therapies in the field of autoimmune diseases. Its core management team consists of seasoned professionals from multinational pharmaceutical companies and biotechnology firms, with expertise in drug development and business expansion.